Please login to the form below

Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans

Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US.

We’re delighted to announce the addition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US, to the Fishawack Health group. Fishawack Health is the parent company of Blue Latitude Health, we unite with the capabilities across the group to best serve our clients' needs.

Skysis brings with it the ability to connect interdependencies across healthcare profession, payer, channel, and patient stakeholders. It is the first acquisition with Fishawack Health’s new investor Bridgepoint. The acquisition bolsters our strong consulting capabilities and furthers our skills in market access.

Clients can benefit from these services across our three capabilities – marketing and commercial consulting, medical communications, and commercial and creative execution. Each of these services is underpinned shared world-class resources, including digital expertise, insight, data analytics and visualisation, and media and production. These capabilities work independently or combine seamlessly as one unit, complete with teams tailored to the client’s individual needs and challenges. As a result, our clients can utilise Skysis’ skills in combination with a wide range of services.

Oliver Dennis, Fishawack Health co-founder and CEO, said: “In partnering with Bridgepoint, we have made a step-change in our ambition. We’re delighted today to add Skysis to the group. They bring strategy and market access across the entire commercial life cycle, making them an important addition to our strategic consulting capabilities.”

Fred Bassett, Head of Consulting for Fishawack Health, added: “Skysis provides strategy and execution across every stage of the commercial life cycle. The company’s expertise bolsters Fishawack Health’s strong strategic consulting team, which includes analysts, researchers, commercial consultants, market access and customer experience specialists, and boasts a network of Physician Expert Partnerships.”

Providing further detail, Dan Twibell Managing Director of Skysis, explained: “We wanted to partner with a group that could help us scale our business, offer more solutions to our clients and that our team would be excited to join.”

Dawn Rich, Managing Director of Skysis, said: “Our team is thrilled to be joining Fishawack Health. Our core capabilities match perfectly with the key services of the wider consulting capability.”

Our strategic and scientific focus as a united group makes us ideally placed to solve complex brand, portfolio and enterprise-level challenges for its clients. With experience across every major therapeutic category, we understand what it takes to improve patient outcomes and drive business success. Fishawack Health will continue to add new capabilities designed to solve our client’s critical medical and commercial challenges in an integrated and seamless way.

Contact hello@bluelatitude.com to find out how we can help you solve your healthcare challenges.

20th April 2020

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Fishawack Health launches global ‘PsoriasIS NOT CONTAGIOUS’ mask campaign for World Psoriasis Day 2020
Fishawack Health launches global disease awareness campaign, supported by the community of Psoriasis Warriors to de-stigmatize psoriasis during the COVID-19 pandemic.
Blue Latitude Health
Fishawack Health, a new breed of global commercialization partner, fit for a post pandemic world
Our parent company, Fishawack Health has reorganized to deliver agile and innovative solutions for life-sciences companies in the face of rapidly changing markets
Blue Latitude Health
In the precision medicine era, the line between products and services is blurred
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?
Blue Latitude Health
Understanding COVID-19 and varying responses across the globe
At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
Blue Latitude Health
Top 5 tips for a multi-indication product launch
Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.
Blue Latitude Health
If our patients are diverse, why are clinical trials so white?
Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
Blue Latitude Health